Tailored messaging that helps life science companies win over the people who influence budgets, adoption, and growth

Our approach has helped clients reach the first page of Google and AI search, contribute to a 37% boost in sales revenue, and communicate complex science clearly to investors, scientists, executives, and clinicians

Content Strategy

Content Creation

Content Analytics

What changes after working with GenoWrite

"We’ve made minimal edits and seen their writing generate strong leads!"

"His expertise in next-generation sequencing workflows gave us valuable scientific input that bolstered our scientific claims through precision and professionalism."

The case studies GenoWrite curated for our partner propelled sales of their Dysbiosis Test LX in Norway and generated new leads for our multiplex immunoassay instruments and microspheres!

Really nicely written interview! You make me sound eloquent!

Companies we've worked with

I bring scientific, marketing, and leadership teams together to craft scientifically rigorous messaging that unifies your brand and moves sales conversations forward.

How GenoWrite's central dogma identifies the most important narratives and tailors them to each stakeholder

Consult

We begin by breaking down the barriers to revenue. By consulting with teams across your company, we audit your current content ecosystem to uncover where messaging gaps are costing you opportunities to secure buy-in. We then build a roadmap to strengthen your messaging across the audiences that matter most.

Compose

We turn strategy into sales assets: From that roadmap, we produce high-leverage collateral, from sales decks to white papers, that maintains scientific accuracy while delivering a unified voice that resonates with researchers, lab managers, executives, and other decision-makers alike.

calibrate

We measure what matters. Lastly, we establish a framework for tracking how your messaging performs commercially. By using that data to refine the strategy over time, we ensure your messaging adapts to market shifts and continues delivering measurable return on investment.